The CHRONOS study: Can the sleep-deprivation induced antidepressive effect in patients with major depression be sustained by correction of diurnal rhythms, long term light treatment and duloxetine treatment?
Phase of Trial: Phase III
Latest Information Update: 25 May 2016
At a glance
- Drugs Duloxetine (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 11 Aug 2009 Actual patient number (75) added as reported by ClinicalTrials.gov.
- 11 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.